BioXcel Therapeutics, Inc. Payments to Acquire Productive Assets
BioXcel Therapeutics, Inc. (BTAI) reported Payments to Acquire Productive Assets of $868.00 thousand for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-14.
Discontinued › Cash Flow
us-gaap:PaymentsToAcquireProductiveAssets · last filed 2019-11-14
- BioXcel Therapeutics, Inc. payments to acquire productive assets for the quarter ending 2019-09-30 was $43.00K, a 30.65% decline year-over-year.
- BioXcel Therapeutics, Inc. payments to acquire productive assets for the quarter ending 2019-06-30 was $225.00K.
- BioXcel Therapeutics, Inc. payments to acquire productive assets for the quarter ending 2019-03-31 was $600.00K.
- BioXcel Therapeutics, Inc. payments to acquire productive assets for the quarter ending 2018-09-30 was $62.00K.
| Period end | Payments to Acquire Productive Assets 3 month | Payments to Acquire Productive Assets 6 month | Payments to Acquire Productive Assets 9 month |
|---|---|---|---|
| 2019-09-30 | $43.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $268.00K derived: sum of 2 quarters · filed 2019-11-14 | $868.00K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $225.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $825.00K 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $600.00K 10-Q · filed 2019-05-07 | ||
| 2018-09-30 | $62.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $182.00K 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $120.00K 10-Q · filed 2019-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |